Rakovina Therapeutics Inc.
RKV:TSX.V
Streetwise Company Fact Sheet2026/3/2 21:01:46
(RKV:TSX.V)
Analyst coverage
| Leede Financial Inc. — Dr. Douglas Loe |
| First Berlin Equity Research — Christian Orquera |
| First Berlin Equity Research — Alexander Rihane |
Company News
| View Latest News |
Streetwise Reports Articles
| 02/24/2026 - View Article |
| 02/09/2026 - View Article |
| 01/12/2026 - View Article |
| 01/09/2026 - View Article |
| 12/04/2025 - View Article |
Streetwise - Rakovina Therapeutics Inc. Ownership Overview*
Rakovina Therapeutics Inc. (RKV:TSX.V)
*Share Structure as of 2/24/2026
Company News
1/27/2026 – Rakovina Therapeutics Announces Corporate Update Including up to $1.5 Million in New Financing, Leadership Appointments and Debt Restructuring
1/8/2026 – Rakovina Therapeutics and Variational AI Expand Collaboration to Advance Next-Generation ATR Inhibitors
12/10/2025 – Rakovina Therapeutics Announces Upcoming Webinar with Variational AI
© 2026 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
